Life Sciences
Reglagene, LLC
Year
2018
Gene abnormalities often result in the manufacture of too little or too much protein causing a myriad of life-threatening diseases, such as cancer. Reglagene's medicines target the protein production problem at the source, the gene, and gets it back to functioning properly.
Website
Company Status
Active
U of A Inventors
Laurence Hurley
Vijay Gokhale
Hyunjin Kang
Andrew Kraft
Jin Song
Kui Wu
College
College of Pharmacy, College of Medicine, BIO5 Institute, UArizona Cancer Center